astrazeneca

Welcome to the 'astrazeneca' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'astrazeneca'.

Are you an expert about 'astrazeneca'? Do you want to be the Technorati authority on 'astrazeneca'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “astrazeneca”

 

• The Forward Look, w/c 30 January

  
  The Share Centre Blog — Authority: 119
  Sheridan Admans gives his thoughts on what to expect from companies announcing results in the coming week. Tuesday Babcock (Trading update) The last update painted an improving picture, with an attractive pipeline of potential contracts. Investors will be hoping that this can be rubber stamped, possibly with ...
  3 days ago

• Big Pharma testing waters with mobile tech

  
  FierceBiotech IT — Authority: 411
  Developers of mobile technologies have made some inroads with deep-pocketed drugmakers, which have sought the help of new apps and devices to streamline the development, marketing and sales of meds. Tech and biopharma entrepreneurs are betting that Big Pharma has an appetite for more mobile innovations. With drug ...
  6 days ago

• Up And Down The Ladder… Job Changes

  
  Pharmalot — Authority: 582
  Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants to know who is coming and going, especially with all the ...
  1 week ago

• Pharmalot… Pharmalittle… The Weekend Nears

  
  Pharmalot — Authority: 582
  And so, another working week is about to draw to a close. As you know, this is our signal to daydream about weekend plans. In fact, we already have a list, which includes spending time with our short and not-so-short people, and catching up with some favorite relatives. Oh yes, a few naps are planned, as well. And ...
  1 week ago

• Neuro Drug Focus end of year late-stage results

  
  The Pharmaceutical News — Authority: 99
  Link to this post! Neuro Drug Focus end of year late-stage results " onclick="javascript:this.select()" readonly="readonly" style="width: 100%;" /> The latest post from: The Pharmaceutical News
  1 week ago

• Takeda Plans To Cut 2,800 Jobs In US & Europe

  
  Pharmalot — Authority: 582
  Three months after completing its $13 billion acquisition of Nycomed, Takeda Pharmaceuticals now plans to cut roughly 10 percent of its workforce, or 2,800 jobs - about 2,100 from Europe and 700 from the US - by 2016 in order to save approximately $2.6 billion. The reorganization will include closing an unspecified ...
  1 week ago

• Researchers Identify Possible Receptor for Key Breast Cancer Regulator

  
  Net News Publisher — Authority: 138
  A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the binding partner of Tumor Differentiating Factor (TDF), a pituitary hormone that had previously been shown ...
  1 week ago

• PARP inhibitors could aid larger ovarian cancer patient population

  
  FierceBiotech Research — Authority: 411
  PARP inhibitors are a promising new class of drugs thought to be an effective weapon against ovarian cancer, among others. But scientists have asserted that no more than 15% of women with the disease--those who have two specific protein mutations--can benefit from the treatment. That may no longer be true. Based on a ...
  2 weeks ago

• (QGEN) Qiagen Expands with New Deals

  
  Stock Blog Hub — Authority: 126
  In an attempt to expand its companion diagnostic portfolio for several types of new anti-cancer... Visit StockBlogHub to view complete post.
  2 weeks ago

• Doc In AstraZeneca Bribe Scandal Commits Suicide

  
  Pharmalot — Authority: 582
  A key figure in a scandal in which AstraZeneca was indicted in Serbia over allegations of offering bribes to physicians has committed suicide. Nenad Borojevic, who was the former director of the Serbian Institute of Oncology and Radiology Nenad Borojevic, was found hanging from a tree in a forest in Belgrade, ...
  2 weeks ago

• Up And Down The Ladder… Job Changes

  
  Pharmalot — Authority: 582
  Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants to know who is coming and going, especially with all the ...
  2 weeks ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 582
  Rise and shine. Another sunny day is on the way. And, of course, that means we will celebrate with a delicious cup of stimulation. We urge you to join us. After all, what better way to prepare for a busy schedule of meetings and deadlines. To help you along, we have gathered a few items of interest. So dig in and ...
  2 weeks ago

• Marks & Spencer lifted by food sales, while Debenhams beats forecasts

  
  The Guardian - guardian.co.uk — Authority: 962
  Marks reported food sales up 3% but general merchandise disappoints, as FTSE regains ground helped by miners Game Group might have shocked investors with a profit warning - with a subsequent 26% fall in its share price - but other retailers have fared better. Marks & Spencer said discounts had helped it ...
  2 weeks ago

• GlaxoSmithKline drops on drug trial results, while AstraZeneca gives City wrong data

  
  Business: Market Forces blog | guardian.co.uk — Authority: 114
  GlaxoSmithKline files for regulatory approval of lung drug, but analysts note concerns about the treatment In another hesitant market, drugs companies are in focus, and not in a good way. GlaxoSmithKline is down 36.5p at 1460.5p or nearly 2.5%, the biggest faller in the leading index. The company said it would ...
  2 weeks ago

• Why income investors can safely ignore FTSE 100 volatility

  
  Telegraph.co.uk Finance Blog — Authority: 579
  Perhaps after all the pundits’ gloomy New Year predictions it was inevitable that the FTSE 100 would come roaring out of the stocks on its first day’s trading in 2012. Rising by 2.3pc on Tuesday, it regained almost half the ground it lost in the previous 12 months during a single session. While such short-term ...
  3 weeks ago

• AstraZeneca Can Sue South Carolina: Judge

  
  Pharmalot — Authority: 582
  Late last month, a South Carolina state court judge gave AstraZeneca a holiday gift - he denied a motion by state Attorney General Alan Wilson to dismiss a lawsuit the drugmaker filed last March. And AstraZeneca filed that lawsuit in response to a 2009 lawsuit brought by Wilson, who sought to recover funds spent to ...
  3 weeks ago

• Why 2012 will be a ‘make or break’ year for savers and investors

  
  Telegraph.co.uk Finance Blog — Authority: 579
  After a dismal decade of falling share prices and rising inflation, 2012 will be a ‘make or break’ year for millions of savers and investors. Fear has replaced greed as the dominant emotion in global stock markets and there are signs that many individual shareholders are about to ‘throw in the towel’ – or ...
  4 weeks ago

Comments about astrazeneca